article thumbnail

SEC’s New Rules Give SPACs, Target Companies Much to Consider

JD Supra: Mergers

The new rules affect both initial public offerings (“IPOs”) for SPACs and so-called “de-SPAC” transactions involving target companies who enter into a business combination with SPACs. On January 24, 2024, the U.S.

article thumbnail

Disclosure of Preliminary Merger Negotiations: Are SPACs Different?

Deal Lawyers

Last week, the SEC announced settled enforcement proceedings against Cantor Fitzgerald for its alleged role in causing two SPACs that it controlled to make misleading statements to investors about the status of their discussions with potential acquisition targets ahead of their initial public offerings (IPOs).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Google’s Plan to Buy Wiz for $23 Billion Falls Apart

The New York Times: Mergers, Acquisitions and Dive

Wiz’s chief executive said the company walked away from a “humbling offer” and would pursue an initial public offering instead.

article thumbnail

Dual Track Reboot: Five Key Considerations for Supercharging Your Life Science Company Exit

JD Supra: Mergers

There have been 44 initial public offerings (IPOs) listed on the US stock markets in 2024 thus far, many of which continue to trade at a premium to their initial offering price, demonstrating the strength and buoyancy of current public markets.

article thumbnail

Guide to D&O Insurance for SPAC IPOs, 2024 Edition

JD Supra: Mergers

As they go through their initial public offering (IPO) and the subsequent merger & acquisition (M&A) process, special purpose acquisition companies (SPACs) face many regulatory, legal, and business hurdles. Obtaining the appropriate amount and type of insurance for each stage of their life cycle is one of them.

IPO 161
article thumbnail

UK and European M&A: Predictions for 2024

JD Supra: Mergers

2023 was a challenging year for mergers and acquisitions (M&A). Overall, in 2023, initial public offering (IPO) activity and. Whilst M&A in the Europe, Middle East and Africa region (EMEA) remained resilient in the first half of 2023, deal activity fell in the second half of the year.

M&A 161
article thumbnail

2024 Technology and Life Sciences IPO Report

JD Supra: Mergers

Wilson Sonsini's 2024 Technology and Life Sciences IPO Report provides in-depth analysis on 33 initial public offerings (IPOs) completed by U.S.-based based technology and life sciences companies in 2024 with deal values exceeding $75 million. By: Wilson Sonsini Goodrich & Rosati

IPO 161